Standard BioTools Operating Margin 2010-2024 | LAB

Current and historical operating margin for Standard BioTools (LAB) over the last 10 years. The current operating profit margin for Standard BioTools as of December 31, 2024 is -63.67%.
Standard BioTools Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-12-31 $0.18B $-0.18B -100.57%
2024-09-30 $0.16B $-0.16B -105.13%
2024-06-30 $0.14B $-0.15B -112.50%
2024-03-31 $0.13B $-0.12B -93.70%
2023-12-31 $0.11B $-0.08B -71.70%
2023-09-30 $0.11B $-0.08B -72.38%
2023-06-30 $0.11B $-0.08B -79.25%
2023-03-31 $0.10B $-0.11B -109.28%
2022-12-31 $0.10B $-0.12B -118.18%
2022-09-30 $0.11B $-0.11B -97.27%
2022-06-30 $0.11B $-0.10B -86.73%
2022-03-31 $0.13B $-0.08B -60.80%
2021-12-31 $0.13B $-0.07B -51.15%
2021-09-30 $0.14B $-0.07B -52.90%
2021-06-30 $0.15B $-0.06B -38.93%
2021-03-31 $0.14B $-0.06B -38.19%
2020-12-31 $0.14B $-0.05B -36.69%
2020-09-30 $0.13B $-0.04B -34.13%
2020-06-30 $0.11B $-0.05B -46.43%
2020-03-31 $0.11B $-0.05B -46.49%
2019-12-31 $0.12B $-0.05B -44.83%
2019-09-30 $0.12B $-0.05B -46.55%
2019-06-30 $0.12B $-0.05B -43.70%
2019-03-31 $0.12B $-0.05B -42.74%
2018-12-31 $0.11B $-0.05B -43.75%
2018-09-30 $0.11B $-0.05B -43.52%
2018-06-30 $0.10B $-0.05B -49.04%
2018-03-31 $0.10B $-0.05B -52.94%
2017-12-31 $0.10B $-0.06B -57.28%
2017-09-30 $0.10B $-0.07B -68.00%
2017-06-30 $0.10B $-0.07B -72.16%
2017-03-31 $0.10B $-0.07B -71.29%
2016-12-31 $0.10B $-0.07B -70.19%
2016-09-30 $0.11B $-0.07B -62.73%
2016-06-30 $0.12B $-0.06B -50.43%
2016-03-31 $0.12B $-0.06B -47.46%
2015-12-31 $0.12B $-0.05B -43.97%
2015-09-30 $0.12B $-0.05B -39.83%
2015-06-30 $0.12B $-0.05B -43.70%
2015-03-31 $0.12B $-0.05B -41.53%
2014-12-31 $0.12B $-0.05B -44.44%
2014-09-30 $0.11B $-0.05B -44.76%
2014-06-30 $0.09B $-0.04B -41.94%
2014-03-31 $0.08B $-0.03B -37.80%
2013-12-31 $0.07B $-0.02B -26.76%
2013-09-30 $0.07B $-0.02B -25.76%
2013-06-30 $0.06B $-0.02B -26.23%
2013-03-31 $0.06B $-0.02B -28.07%
2012-12-31 $0.05B $-0.02B -32.08%
2012-09-30 $0.05B $-0.02B -34.00%
2012-06-30 $0.05B $-0.02B -35.42%
2012-03-31 $0.05B $-0.02B -43.48%
2011-12-31 $0.04B $-0.02B -43.18%
2011-09-30 $0.04B $-0.02B -43.90%
2011-06-30 $0.04B $-0.02B -44.74%
2011-03-31 $0.04B $-0.01B -40.00%
2010-12-31 $0.03B $-0.01B -42.42%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.399B $0.174B
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.307B 54.29
Hims & Hers Health (HIMS) United States $13.112B 136.23
Tempus AI (TEM) United States $10.781B 0.00
IRhythm Technologies (IRTC) United States $4.503B 0.00
Inspire Medical Systems (INSP) United States $4.415B 68.98
Privia Health (PRVA) United States $3.036B 207.50
Enovis (ENOV) United States $2.041B 11.38
Clover Health Investments (CLOV) United States $1.735B 0.00
Schrodinger (SDGR) United States $1.706B 0.00
Phreesia (PHR) United States $1.529B 0.00
Omnicell (OMCL) United States $1.315B 23.21
Azenta (AZTA) United States $1.223B 56.83
10x Genomics (TXG) United States $1.125B 0.00
Fulgent Genetics (FLGT) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Talkspace (TALK) United States $0.500B 149.50
Veradigm (MDRX) United States $0.482B 0.00
Claritev (CTEV) United States $0.450B 0.00
TruBridge (TBRG) United States $0.368B 816.67
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.207B 0.00
EUDA Health Holdings (EUDA) Singapore $0.147B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00